We started this year on a high note with the FDA’s approval of 37 novel drugs in 2022, of which 20 are for treatment of rare disease. Our vision to support transformative medicines for a healthier future motivates us to deepen our...
The Adoption of ICH M10 The ICH M10 provides international harmonized guidance on the validation of bioanalytical assays and the performance of study sample analysis. The following webinars with industry experts will focus on...
AAPS PharmSci 360 Happy Hour at the AAPS 2022 PharmSci 360 Join us at booth #631 Monday, October 17, from 3:00-4:00 PM for a networking event sponsored by Sustaining Partner Alturas Analytics. Poster Presentation: Validation of an...
ACT 2022 Annual Meeting The American College of Toxicology is a global community of scientists representing the pharmaceutical and biotech industries focused on education, leadership, and service. Join Alturas Analytics for a week of...
The Boston Society APA The annual forum on Applied Pharmaceutical Analysis is a full-spectrum program of activities encompassing mechanistic understanding, facets of development processes, and the technologies necessary to discover and...
ISSX/MDO 2022 Meeting The International Society for the Study of Xenobiotics (ISSX) is a community of accomplished researchers and future scientists from academia and industry collaborating to advance the collective knowledge of...
AAPS Land O' Lakes Bioanalytical Conference The annual Land O’ Lakes Bioanalytical Conference brings together experts from the field of bioanalysis to discuss innovations, challenges, and applications associated with the analysis of...
Alturas Analytics, Inc. is aware of the Log4j software vulnerability and has assessed our systems accordingly. We do not anticipate any issues as most of our applications do not utilize the systems exploited for an attack. Alturas' IT...
As research continues through the COVID-19 pandemic, the need to continue operations as usual and manage critical timelines within regulatory compliance presents unprecedented challenges for the entire pharmaceutical industry. Due to the...
Alturas’ Information Technology department has made critical and expedient changes to support our business continuity plan and adapt to the changing workflow influenced by the coronavirus. To enable more employees to work from home, we...
